Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
Fampridine and quality of life in individuals with multiple sclerosis.
Vibration training improves disability status in multiple sclerosis: A pretest-posttest pilot study.
Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination.
Autoimmunity in 2015.
Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression.
Sunlight exposure: Do health benefits outweigh harm?
Significant Functional Improvement in a Person with Multiple Sclerosis Utilizing Dynamic Neuromuscular Stabilization: 1333 June 2, 8: 00 AM - 8: 20 AM.
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
Managing the Quality of Life in Patients with Multiple Sclerosis: A Literature Review.
Parametric Probability Distribution Functions for Axon Diameters of Corpus Callosum.
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
Learning Objectives.
Lesson of the month 1: Post-malaria neurological syndromes.
Fixing the jugular flow reduces ventricle volume and improves brain perfusion.
Radiological-pathological correlation of diffusion tensor and magnetization transfer imaging in a closed head traumatic brain injury model.
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients.
Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages.
Key Points for Issue.
Neuronal death in the dorsal root ganglion after sciatic nerve injury does not depend on sortilin.
Diagnostic Utility of Systematic Aquaporin-4 Antibodies Determination in the First Event of Immune-Mediated Optic Neuritis.
Thymoquinone Alleviates the Experimental Diabetic Peripheral Neuropathy by Modulation of Inflammation.
Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail.
Clinical aspects of symptomatic hyponatremia.
Pages
« first
‹ previous
…
761
762
763
764
765
766
767
768
769
…
next ›
last »